Skip to content

Biotech ETF

A Diamond In The Rough & 2 Other Top Biotech Stock Picks For 2021

One of the strongest biotechs out there, a diamond in the rough, and a high-risk, high-reward play make up the three biotech stocks identified by the author of today’s article as top picks for 2021 for investors looking for even better biotech returns than those offered by broad biotech ETFs such as the SPDR S&P Biotech ETF. For a look… 

CLICK HERE »A Diamond In The Rough & 2 Other Top Biotech Stock Picks For 2021

ETFs: A Remedy For Biotech Risks

The solution to the substantial risks associated with biotech stocks (especially small biotech firms)? Biotech ETFs! Today’s article highlights six biotech ETFs to consider buying, noting that “Some provide well-rounded access to the space, while others acutely focus on certain aspects of the space, such as cancer treatments or drugs to battle infectious diseases.” For these six biotech ETFs, CLICK… 

CLICK HERE »ETFs: A Remedy For Biotech Risks